SCHEMBL754428

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL752971	0.89	LIPG (0.49)	LIPGLTA4HIDH1
	SCHEMBL754703	0.85	LIPG (0.47)	LIPGPOLBL3MBTL1
	SCHEMBL754568	0.84	ACACB (0.40)	LIPGLTA4HCYP11B1CYP11B2BTK
	SCHEMBL752853	0.84	LIPG (0.42)	LIPGACACB
	SCHEMBL753739	0.80	LIPG (0.43)	LIPGGRIA2ACACB
	SCHEMBL752750	0.78	NPC1 (0.50)	LIPGL3MBTL1
	SCHEMBL754314	0.75	LIPG (0.48)	LIPGPOLB
	SCHEMBL755290	0.75	LIPG (0.50)	LIPGLTA4HIDH1
	SCHEMBL754214	0.75	LIPG (0.45)	LIPGL3MBTL1
	SCHEMBL756168	0.74	IDH1 (0.38)	LIPGL3MBTL1IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.